After a breast cancer diagnosis, you’ll find yourself in a new world that speaks a different language. Your oncologist will refer to new terms like: mammography report, cancer stages and symptoms, surgery options, chemotherapy, radiation, pathology results, metastasis, tumor markers, clinical trials . . . it’s information overload. How can you communicate with your oncology team about something that is so foreign to you? There is a way that you can understand all of these terms and more as they pertain to you, personally, from the comfort of your own home by using the Nexprofiler Treatment Option Tool for Breast Cancer. Whether you are newly diagnosed, or are experiencing a recurrence after previous treatment, this tool will enable you to become an active participant in your treatment decisions. When you log in the site for the first time, you will answer a questionnaire about your breast cancer diagnosis. You don’t have to know all the answers about your diagnosis. Nexprofiler will generate a report from your answers that will include questions to take to your oncology team to fill in any information you lack. Not only that, but your report will also include information about your personal treatment plan including side effects you may not be aware of as well as access to information about clinical studies. Recommended by the American Cancer Society, the Nexprofiler Treatment Option Tool for Breast Cancer is a free service, and they will never share your personal information with anyone without your permission. It’s an opportunity to weigh the pros and cons of your personal breast cancer treatment in a non-pressure situation, know the right questions to ask your oncology team, and learn to speak the language of breast cancer at your own pace.
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.